Control of the Autophagy Pathway in Osteoarthritis: Key Regulators, Therapeutic Targets and Therapeutic Strategies

Int J Mol Sci. 2021 Mar 7;22(5):2700. doi: 10.3390/ijms22052700.

Abstract

Autophagy is involved in different degenerative diseases and it may control epigenetic modifications, metabolic processes, stem cells differentiation as well as apoptosis. Autophagy plays a key role in maintaining the homeostasis of cartilage, the tissue produced by chondrocytes; its impairment has been associated to cartilage dysfunctions such as osteoarthritis (OA). Due to their location in a reduced oxygen context, both differentiating and mature chondrocytes are at risk of premature apoptosis, which can be prevented by autophagy. AutophagomiRNAs, which regulate the autophagic process, have been found differentially expressed in OA. AutophagomiRNAs, as well as other regulatory molecules, may also be useful as therapeutic targets. In this review, we describe and discuss the role of autophagy in OA, focusing mainly on the control of autophagomiRNAs in OA pathogenesis and their potential therapeutic applications.

Keywords: autophagy; chondrocytic commitment; mesenchimal stem cells; miRNAs; osteoarthritis.

Publication types

  • Review

MeSH terms

  • Animals
  • Autophagy / drug effects
  • Autophagy / physiology*
  • Cell Differentiation
  • Cellular Senescence / drug effects
  • Chondrocytes / cytology
  • Chondrocytes / physiology
  • Disease Models, Animal
  • Humans
  • MicroRNAs
  • Osteoarthritis / drug therapy*
  • Osteoarthritis / pathology*
  • Transcription Factors / genetics
  • Transcription Factors / metabolism

Substances

  • MicroRNAs
  • Transcription Factors